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Introduction: Microspheres fabricated from natural materials serve as a promising biodegradable and
biocompatible carrier in a small volume for efficient cell delivery to the lesion of the injured neural tissue to
generate biological functions. As the major component of extracellular matrix and due to its natural abundance
within the body, collagen may be fabricated into microspheres and improve the ability of pre-seeded cells on the
microspheres to encounter the hostile micro-environment in the lesion.
Methods: In this study, collagen microspheres were fabricated using the water-in-oil emulsion technique and cross-
linked with 1-ethyl-3-(3-dimethylaminopropryl) carbodiimide. Oligodendrocyte progenitor cells isolated from
postnatal day P1 to 2 rats were cultured and differentiated on the microspheres. The microspheres carrying the
oligodendrocyte progenitor cells were co-cultured with dorsal root ganglions from 15-day-old rat embryos. The
myelination formation was studied for the co-culture of oligodendrocyte progenitor cells and dorsal root ganglions.
Results: We showed that the viability of oligodendrocyte progenitor cells, B104 cells and PC12 cells grown on
microspheres was not significantly different with those in cell culture plates. Oligodendrocyte progenitor cells
differentiated into oligodendrocytes on collagen microspheres. The oligodendrocytes grown on microspheres
extended processes that wrapped the axons of dorsal root ganglion neurons and the formation of myelin sheath
was observed in the co-culture.
Conclusions: This study demonstrates the feasibility of collagen microspheres in further applications for the
delivery of neural progenitor cells for neural regeneration.
Keywords: Microsphere, Oligodendrocyte, Cell delivery, Co-culture, Neural regeneration, Dorsal root ganglionIntroduction
Oligodendrocytes (OLs) undergo both necrosis and
apoptosis shortly after spinal cord injury (SCI). Loss of
OLs causes demyelination and thereby impairs axon
function and survival [1-3]. In response to demyelin-
ation, the oligodendrocyte progenitor cells (OPCs),
which produce the proteoglycan NG2 and express the
platelet-derived growth factor-α receptor on the cell
membrane, are recruited from gray and white matter
and migrate to the demyelinated site [4]. Direct evidence
showed that OPCs will replace mature OLs after SCI* Correspondence: li.yao@wichita.edu
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reproduction in any medium, provided the orand differentiate into OLs that eventually myelinate the
axon [5]. Axon remyelination after SCI typically begins
around two weeks post-injury and the endogenous
oligogenic response is insufficient against OL loss and
demyelination post-SCI. Transplantation of OPCs is po-
tentially an efficient approach to remyelinate regenerat-
ing axons and to recover the spinal cord function after
injury [6,7]. However, the microenvironment that the
transplanted cells will encounter is the major concern in
the process. Previous study showed that very few neural
stem cells (NSCs) survive if directly transplanted to the
site of damage [8]. Biomaterial scaffold delivery of the. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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proved the survival of the transplanted cells [9,10].
Micro- and nano-scale carriers fabricated from various
natural and synthetic polymers have shown significant
potential in biomedical and pharmaceutical applications.
To encapsulate biomolecules in the particles to be deliv-
ered to the target tissues, the particles are able to gener-
ate a significant biological effect through a small volume
[11-14]. Cell delivery and transplantation to the targeting
tissue is an alternative application of the particles for the
delivery of biomolecules. The investigation of micro-
spheres for stem cell growth was reported in previous
studies, which demonstrated a great potential of micro-
spheres in stem cell delivery for tissue regeneration
[15-17]. However, the feasibility of microspheres for
neural progenitor cell growth for the repair of central
nervous system has not been studied. Microspheres may
provide the neural progenitor cells pre-seeded on the
microspheres an optimal condition for the cells to adapt
to the hostile environment in the lesion. The investiga-
tion of the growth, differentiation and ability for
myelinating neurites of oligodendrocyte progenitor cells
on microspheres will provide valuable information for
its application in in vivo neural regeneration studies.
Collagen is the major component of extra-cellular
matrix. Due to its natural abundance within the animal
body, and its biodegradability and biocompatibility, col-
lagen has been fabricated into microspheres and investi-
gated for gene, growth factors and stem cell delivery
[17-19]. Microspheres fabricated from collagen may
work as efficient carriers for oligodendrocyte progenitor
cell proliferation and differentiation, and can be poten-
tially used to deliver OPCs to myelinate regenerating
spinal axons of the injured spinal cord. In this study, we
will investigate the growth and differentiation of OPCs
on collagen microspheres and study myelination of the
axons of dorsal root ganglion (DRG) neurons by OPCs
carried by collagen microspheres in vitro. This study will
provide us with important information for the further
study of repairing the injured spinal cord using collagen
microspheres delivering OPCs in the animal model.
Methods
Collagen microsphere fabrication
The collagen microspheres were fabricated as reported
[19]. In brief, Type I collagen (extracted from bovine Achil-
les tendon) solution (5 mg/ml) emulsified in liquid paraffin
oil (Sigma-Aldrich, St. Louis, MO, USA) containing surfac-
tant (Span 20, Sigma-Aldrich) (0.3% (v/v)) and stirred using
a ceramic-top stirring plate (Fisher Scientific, Pittsburg, PA,
USA) for five minutes. 1-ethyl-3-(3-dimethylaminopropryl)
carbodiimide (EDC) (Sigma-Aldrich) (50% in water (v/v))
was added to the emulsified mixture, and was stirred
for 1 h to form collagen microspheres. Ethanol (50% (v/v)in water) was then added into the mixture and stirred for
five minutes to separate the collagen microspheres from
the oil phase. The mixture was then centrifuged at
3,500 rpm for five minutes. This step was repeated three
times to remove the supernatant. The collagen microspheres
were washed with sterile phosphate-buffered saline
(PBS) and centrifuged again (3,500 rpm five minutes) to
remove the supernatant. Sterile PBS was added to the
centrifuge tube to re-suspend the microspheres and the
tube with the microsphere suspension was stored at 4°C
before the cells were seeded. In the studies of cell viability
assay and the co-culture of microspheres delivered OPCs
and DRGs, 20% of microspheres generated by 1 ml colla-
gen solution were placed in each well of a 48-well plate.
The microspheres fully covered the bottom of the well
and cells were seeded on top of the microspheres. To
study the OPCs’ growth and differentiation on collagen
microspheres with immunocytochemistry, 5% of the mi-
crospheres generated by 1 ml collagen solution were
placed in each well of a 48-well plate. The immunolabeled
cells on microspheres and on a cell culture plate can be
easily visualized with the low density of the microspheres
in the cell culture wells.OPCs isolation and culture
Procedures used in animal experiments were approved
by the Institutional Animal Care and Use Committee
(IACUC) and completed at the Wichita State University,
Wichita, KS, USA. OPC cultures were established as
reported previously [20]. In brief, postnatal day P1 to 2
rats were sacrificed and cerebral cortexes were isolated
from the brain. The cortex tissues were each triturated
gently and sequentially twice through needles with a
1-cc syringe. The tissue suspension was passed through a
70 mm nylon cell strainer (BD Falcon™, Durham, NC,
USA) which was placed on a 50 ml conical tube and the
flow-through was collected. The isolated cells were cul-
tured for about seven days. The OPCs were then isolated
from the mixed cell culture layer by mechanically shaking
the cell culture flasks. The collected OPCs were cultured
in cell culture dishes coated with Poly-D,L-ornithine
(5 mg/ml in PBS, Sigma-Aldrich). The OPCs were fed
with OPC growth medium containing DMEM (Life
Technologies™, Grand Island, NY, USA), Sato media
(DMEM, 100 μg/ml transferrin, 100 μg/ml BSA, 0.2 μM
progesterone, 16 μg/ml putrescine, 40 ng/ml sodium sel-
enite (Sigma-Aldrich)), 1% penicillin-streptomycin, 2 mM
L-glutamine (Life Technologies™), 5 μg/ml insulin, 10 nM
D-biotin, 1 mM sodium pyruvate, 5 μg/ml N-acetyl cyst-
eine (Sigma-Aldrich), Trace Elements B (1x, Mediatech,
Inc., Manassas, VA, USA) and 10 ng/ml PDGF and 10 ng/ml
bFGF (Peprotech, Rocky Hill, NJ, USA). Then the OPCs
were passaged or grown on collagen microspheres.
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The viability and proliferation of OPCs, B104 cells and
PC12 cells, which were seeded on collagen micro-
spheres, were studied by monitoring their metabolic
activity using alamarBlue assay (Pierce Biotechnology,
Rockford, IL, USA). To perform the alamarBlue assay,
the sterile PBS containing collagen microspheres was
centrifuged and the microspheres were resuspended in
the cell culture medium. The collagen microspheres
were placed into the 48-well plates and the bottom of
the cell culture wells were fully covered by the micro-
spheres. After the microspheres were settled down at the
bottom of the cell culture wells, the cells (15,000 cells/
well) were added into the cell culture medium and the
cells grew on the microspheres. In the control study, the
cells (15,000 cells/well) were directly seeded in 48-well
plates coated with poly-D,L-ornithine (5 mg/ml in PBS).
After culturing for four days, the medium was gently re-
moved from the wells and the cells were then incubated
with culture medium containing 10% (v/v) alamarBlue
reagent for two hours. Then the cell culture medium
containing alamarBlue reagent was transferred to a 96-
well plate (100 μl/well) and absorbance was measured at
a wavelength of 570 nm and 600 nm in a microplate
reader (Synergy Mx Monochromator-Based Multi-Mode
Microplate Reader, Winooski, VT, USA). The cell viabil-
ity of the 3T3 cells and PC12 cells growing on the colla-
gen microspheres was analyzed by fluorescence-based
LIVE/DEAD® assays (Life Technologies™). The Calcein
and EthD-1 labeled cells were counted and quantified to
show the rate of live cells on the collagen microspheres.
DRG isolation and culture
DRGs from 15-day-old Sprague Dawley rat embryos
were isolated and cultured in the collagen-coated 24-
well-plate wells [21]. The whole DRGs were cultured in
Neurobasal media supplemented with B27, 1% penicillin/
streptomycine, 2 mM L-glutamine (Life Technologies™),
20 ng/ml 2.5S nerve growth factor (NGF, Alomone Labs,
Jerusalem, Israel), 8.625 μg/ml uridine and 3.75 μg/ml of
5-fluoro-2- deoxyuridine (Sigma-Aldrich). The DRGs were
cultured for 10 days before they were co-cultured with
OPCs.
OPCs and DRG co-culture
OPCs (15,000 cells/well) were seeded on the collagen
microspheres and cultured with OPCs growth medium
for two days. The collagen microspheres with pre-seeded
OPCs were then transferred into the wells with the
growth of DRGs [22]. In the control group, OPCs
(15,000 cells/well) were added into the DRG culture
wells. The co-culture of the DRG and OPCs were
maintained for eight days in the DMEM with Sato
media, 1% penicillin-streptomycin, 2 mM L-glutamine,5 μg/ml insulin, 10 nM D-biotin, 1 mM sodium pyru-
vate, 5 μg/ml N-acetyl cysteine, Trace Elements B and
Triiodothyronine (Sigma-Aldrich). Negative control was
performed to treat the cultured DRG with the co-culture
medium without adding OPCs in the cell culture.
Immunocytochemistry
OPCs and DRGs were fixed with 4% paraformaldehyde
in PBS solution. The phenotype of the cultured OPCs
was determined with anti-A2B5 antibody (a gift from Dr
Qing Lu, University of Texas Southwestern Medical
Center). The differentiated OPCs were labeled with anti-
O4 antibody (a gift from Dr Qing Lu, University of
Texas Southwestern Medical Center) and anti-Myelin
Basic Protein (MBP) antibody (Millipore, Billerica, MA,
USA). Dual labeling of DRG neuron axons and oligo-
dendrocyte were performed to study the myelination
of the DRG axons using anti-IIIβ-tubulin antibody
(Millipore) and anti-MEB antibody, respectively. The im-
ages were taken using Zeiss Axio Observer microscope
(Carl Zeiss Microscopy, LLC, Thornwood, NY, USA).
Statistics
Statistical analysis was conducted using a two-tailed
Student’s t-test. A P-value of 0.05 was considered to be
statistically significant. Data are expressed as means ±
standard deviation.
Results
Collagen microspheres supported the proliferation of the
cells grown on the surface of the microspheres
Collagen microspheres were fabricated using the water-
in-oil emulsion technique by adding collagen and cross-
linking reagent to a solution containing paraffin oil and
surfactant, and stirring the mixture using a stirring plate
(Figure 1A-C). The diameter of the collagen micro-
spheres decreased from 182.3 ± 8.8 μm to 74.4 ± 3.1 μm
(n = 3, mean ± SD, P <0.01), when the stirring speed in-
creased from 600 rpm to 1,000 rpm (Figure 1G).
The LIVE/DEAD® assay and alamarBlue assay were
performed to analyze the cell viability of the cells grown
on the collagen microspheres. The LIVE/DEAD® assay
showed that most 3T3 cells that grew on the surface of
collagen microspheres were live cells (Figure 1D-F). Fur-
ther quantification showed that after being cultured for
three days, the rate of live cells of 3T3 cells and PC12 cells
was 91.5 ± 4.3% and 94.3 ± 2.9% (n = 3, mean ± SD), re-
spectively, which is not significantly different from that of
the cells that grew in cell culture dishes (Figure 1H). The
alamarBlue assay showed that the reduction of alamarBlue
reagent for the OPCs, B104 cells and PC12 cells grown on
collagen microspheres was 27.9 ± 2.2%, 52.9 ± 1.6%, and
23.1 ± 6.2%, (n = 4, mean ± SD), respectively, which was
not significantly different from that on cell culture plates
Figure 1 Cell viability of the cells grown on the collagen microspheres. (A-C) Fabricated collagen microspheres. The diameter of collagen
microspheres increased when the stirring speed for the mixture of collagen solution, paraffin oil and surfactant was increased. The stirring speeds
for the fabrication of collagen microspheres are 600 rpm (A), 800 rpm (B) and 1,000 rpm (C). Scale bar: 200 μm. (D-F) 3T3 cells that grew on
collagen microspheres were labeled with Calcein (D) and Ethidium (E) in the LIVE/DEAD® cell viability assay. (G) Quantification of microsphere
diameter fabricated at different stirring speed. (H) Quantification of live cells of PC12 cells and 3T3 cells grown in cell culture plate or on collagen
microspheres. Scale bar: 200 μm (I) alamarBlue cell viability assay of B104 cells, PC12 cells and oligodendrocyte progenitor cells (OPCs) growing in
cell culture plate or on collagen microspheres.
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19.5 ± 5.1%) (n = 4, mean ± SD) (Figure 1I).
Collagen microspheres support the differentiation of
OPCs grown on the microspheres
The OPCs grown in the cell culture plate developed mul-
tiple processes and were labeled with anti-A2B5 antibody.
The phenotype and morphology of the OPCs growing on
collagen microspheres were also studied. OPCs were
seeded on the collagen microspheres and cultured with
OPC medium for three days. Then the growth of OPCs
on the collagen microspheres was observed. Immuno-
labeling with anti-A2B5 antibody showed that the OPCs
expressed A2B5 antigen and the OPCs on collagen micro-
spheres developed short processes (Figure 2).
After being cultured for eight days in differentiation
medium, the OPCs differentiated into oligodendrocyteson collagen microspheres and in cell culture dishes
(Figure 3). The differentiated cells in cell culture plates
expressed MBP protein and were labeled with anti-MBP
antibody. The differentiated OPCs grown on collagen mi-
crospheres developed multiple processes and were also
labeled with anti-MBP antibody. The multiple processes
of oligodendrocytes grown on collagen microspheres
surrounded the collagen microspheres. The oligodendro-
cyte growing on the collagen microspheres also extended
processes to the culture dishes and established connec-
tions with other oligodendrocytes (Figure 3E, F).
OPCs seeded on collagen microspheres differentiated and
formed myelin sheaths for neurites of the cultured DRG
neurons
After the co-culture of OPCs and DRGs was maintained
for eight days, OPCs differentiated and developed
Figure 2 Growth of OPCs on collagen microspheres. (A-C) Oligodendrocyte progenitor cells (OPCs) grown in cell culture plate were labeled
with anti-A2B5 antibody. Scale bar: 100 μm. (D-F) Bright field and fluorescent images showed the OPCs grown on collagen microspheres. The
OPCs are labeled with anti-A2B5 antibody. Scale bar: 200 μm. (G-I) A typical microsphere with the growth of OPCs highlights the morphology of
OPCs grown on microspheres. Scale bar: 50 μm.
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DRG neurons. In this study, myelin sheath formation
around the neurites of DRG neurons was observed
(Figure 4B, C). Collagen microspheres pre-seeded with
OPCs were transferred to the cell culture dishes with
the growth of DRGs and the culture was maintained forFigure 3 The differentiation of OPCs on collagen microspheres. (A) D
are labeled with anti-MBP antibody. Scale bar: 200 μm. (B-D) Differentiated O
protein (MBP) antibody. Scale bar: 200 μm. (E) and (F) The morphology of difeight days. Some collagen microspheres attached to the
neurites of the DRG neurons. Oligodendrocytes devel-
oped multiple processes on the collagen microspheres
(Figure 4D). The authors observed that multiple pro-
cesses from the oligodendrocytes grown on micro-
spheres wrapped the DRGs’ neurites (Figure 4E) and theifferentiated oligodendrocyte progenitor cells (OPCs) in cell culture plates
PCs grown on collagen microspheres are labeled with anti-myelin basic
ferentiated OPCs on a collagen microsphere. Scale bar: 50 μm.
Figure 4 Co-culture of DRGs and OPCs carried by collagen microspheres. (A) Co-culture of dorsal root ganglions (DRGs) with oligodendrocyte
progenitor cells (OPCs) in cell culture plate. Scale bar: 200 μm. (B) and (C) Magnified images shows the oligodendrocytes (OLs) wrap DRG neurites.
Scale bar: 50 μm. (D-F) Co-culture of DRGs and OPCs carried by collagen microspheres. Scale bar: 200 μm. (D) Bright field image shows that collagen
microspheres attach to the cell culture plate. The arrows point at the collagen microspheres. (E) and (F) OPCs on collagen microspheres differentiated
into OLs. The processes of OLs wrapped the neurites of DRGs. (G-I) Magnified images for the microsphere indicated by blue arrow in (D) show the
irregular shape of the collagen microsphere and the neurites of DRGs were wrapped by OLs. Scale bar: 100 μm.
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DRG neurons (Figure 4H). In the negative control,
DRGs were cultured in co-culture medium without
adding OPCs in the cell culture. After the DRGs were
cultured for eight days, we did not see any MBP positive
cells in the cell culture.
Discussion
In this study, collagen microspheres were fabricated
using the water-in-oil emulsion technique and cross-
linked with EDC. We showed that the viability of oligo-
dendrocyte progenitor cells, B104 cells and PC12 cells
grown on collagen microspheres was not significantly
different from that in the cell culture plates. We also
showed that OPCs differentiated into oligodendrocytes
on collagen microspheres. The OPCs were then grown
on collagen microspheres and co-cultured with DRGs.
We demonstrated that the oligodendrocytes grown on
microspheres extended processes that wrapped the
axons of DRGs and the myelin sheath formation for the
neurites of DRG neurons was observed.
Microspheres fabricated from biocompatible materials
provide a supportive environment for cell growth, while
the cells growing on the microspheres can also modify
the structure of the microspheres. Previous work showed
that the ability of porous chitosan microspheres can sup-
port adipose-derived stem cell growth [16]. When thespheres were incubated with adipose-derived stem cells
(ADSCs), the spheres proliferated on the surface of the
spheres, as well as infiltrated the pores to grow within
the spheres as well. The cells growing on spheres
maintained their metabolic activity and viability. Because
of its biological and structural properties, type I collagen
has been processed as an engineered scaffold for neural
regeneration [23-25]. EDC cross-linked neural conduits
were fabricated in previous studies and their biocompati-
bility was shown by growing dorsal root ganglion in the
cross-linked collagen conduits [21]. It was also
demonstrated that the EDC cross-linked collagen con-
duits supported peripheral nerve regeneration after the
implantation of neural conduits in the transected rat sci-
atic nerve [26]. In this study, we showed the prolifera-
tion of OPCs, PC12 cells and B104 cells on collagen
microspheres was not significantly different from that in
cell culture plates. We observed that most collagen mi-
crospheres maintained round morphology after the
OPCs were grown on the microspheres for three days.
However, we found the morphology of the microspheres
changed after the OPCs were cultured on the micro-
spheres after eight days. Some round collagen micro-
spheres changed to an irregular morphology. This
suggests the OPCs can gradually re-organize the morph-
ology of the collagen microspheres. In in vivo studies, it
is likely that OPC-grown collagen microspheres will be
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OPCs are cultured on collagen microspheres for two to
four days, as the OPCs can easily maintain their pheno-
type during the period in vitro. After two to four days’
culture, the microspheres should efficiently deliver the
OPCs to the wounded neural tissue. The OPCs are
expected to incorporate into the local tissue with the
degradation of the collagen microspheres.
For the cell transplantation and therapy, stem cells de-
livered by the microspheres need to maintain their
phenotype and their differentiation ability. We observed
that OPCs showed the A2B5 marker in OPCs medium
and differentiated into oligodendrocytes with differenti-
ation medium when they were cultured on collagen
microspheres. We found that the oligodendrocytes
extended processes around the microspheres and
established connection with other oligodendrocytes. This
study suggests that collagen is a biocompatible material
that can support OPC growth and differentiation. The
cross-linking reagent EDC is not toxic to the OPCs. In
this study, 15,000 cells were on microspheres of each
well for viability assay and for co-culture with DRGs.
The concern of significantly increasing the OPCs
seeding density on microspheres is that OPCs cannot
maintain the phenotype and differentiate into oligoden-
drocytes. The OPCs’ seeding density on microspheres
for transplantation studies should be optimized in fur-
ther in vivo studies. Different from the in vitro condi-
tion, after transplantation into the wounded neural
tissue, OPCs may adhere to the surrounding tissue and
grow and some of the OPCs may die off. The optimal
OPCs’ density for transplantation should be higher com-
pared with that for the current study.
Targeting the cell transplantation to the lesion and
therapy, it is important to maintain the cell’s function in
the process of cell encapsulation. In order to ensure this,
the type of polymer used must fulfill appropriate mech-
anical durability, pore size, capsule consistency, degrad-
ation features and low immunogenicity [27]. Therefore,
natural polymers are strongly favored because they are
usually biodegradable, nontoxic and non-immunogenic.
Previous study showed that collagen type I gel can sup-
port the growth of neural stem/precursor cells (NSPCs)
and the NSPCs could differentiate into neurons, astro-
cytes and oligodendrocytes in the collagen gel [28]. In
another study, OPCs were grown on coverslips coated
with fibronectin, laminin or Matrigel and the results
showed that these ECM components enhanced the bio-
logical properties of the OPCs compared with a non-
ECM substrate [29]. Potentially, collagen and fibronectin
can be fabricated as hydrogel or microspheres for OPCs
delivery to treat the injured spinal cord. Different from
the hydrogel approach, which is particularly suitable to
fill neural defect, microspheres could be delivered withPBS to a lesion without significant neural defect because
the size of the microspheres is relatively small. Addition-
ally, as the collagen or fibronectin is mechanically elas-
tic, collagen- or fibronectin-based microspheres will
create little damage to the healthy tissue after implant-
ation. Previous studies showed that the degradation
property of the collagen scaffolds can be modified by
changing cross-linking reagent concentration. The deg-
radation rate of the collagen microspheres can be regu-
lated by modifying the level of the cross-linking reagent.
The degradation of the microspheres will be determined
by in vivo study. The degradation rate can be optimized
by studying the microsphere degradation rate and cell
survival in vivo. The optimal degradation rate is the
maximal OPCs cell survival with the removal of the mi-
crospheres from the host tissue.
Conclusions
In this study we showed that collagen microspheres can
support the growth and differentiation of OPCs that
were seeded on the microspheres. Oligodendrocytes ex-
tended multiple processes that surrounded the collagen
microspheres and wrapped the neurites of the DRGs.
The formation of a myelin sheath was observed in the
co-culture of DRGs and OPCs carried by collagen mi-
crospheres. This study demonstrates the potential of col-
lagen microspheres in the applications of delivery and
transplantation of neural stem cells for neural regener-
ation of in the central nervous system.
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